Crescendo Biologics is a startup based in the United Kingdom, most recent round Series-c-plus, 1 tracked investor.
Based in the United Kingdom, Crescendo Biologics is a startup founded in 1990. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Crescendo Biologics is a clinical-stage immuno-oncology company developing novel T-cell enhancing therapeutics using its proprietary Humabody® platform. They focus on creating differentiated T-cell engager product candidates for solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.